Skip Navigation

JNCI Journal of the National Cancer Institute 2008 100(9):603; doi:10.1093/jnci/djn139
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Nationwide Audit of Cervical Cancer Screening in Sweden

The effectiveness of cervical cancer screening programs differs widely in different populations. To better understand why cervical cancers occur despite organized screening, Andrae et al. (p. 622) conducted a comprehensive nationwide audit of the effectiveness of the organized cervical cancer screening program in Sweden. Not having had a Pap smear taken within the recommended screening interval was the most important risk factor for cervical cancer in the presence of a screening program. The screening program was equally effective for women of all ages, including women younger than 30, and was also effective against nonsquamous cancers. The authors conclude that compliance with . . . [Full Text of this Article]

Cost of Care for Elderly Cancer Patients in the United States

Bortezomib Sensitization of Solid Tumors to TRAIL-Mediated Death

Pesticides and Risk of Testicular Germ Cell Tumors

CYP2D6 Variation and Endocrine Therapy for Breast Cancer

Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden
Bengt Andrae, Levent Kemetli, Pär Sparén, Lena Silfverdal, Björn Strander, Walter Ryd, Joakim Dillner, and Sven Törnberg
J Natl Cancer Inst 2008 100: 622-629. [Abstract] [Full Text] [PDF]

Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis
Rinaa S. Punglia, Harold J. Burstein, Eric P. Winer, and Jane C. Weeks
J Natl Cancer Inst 2008 100: 642-648. [Abstract] [Full Text] [PDF]

Persistent Organochlorine Pesticides and Risk of Testicular Germ Cell Tumors
Katherine A. McGlynn, Sabah M. Quraishi, Barry I. Graubard, Jean-Philippe Weber, Mark V. Rubertone, and Ralph L. Erickson
J Natl Cancer Inst 2008 100: 663-671. [Abstract] [Full Text] [PDF]

Cost of Care for Elderly Cancer Patients in the United States
K. Robin Yabroff, Elizabeth B. Lamont, Angela Mariotto, Joan L. Warren, Marie Topor, Angela Meekins, and Martin L. Brown
J Natl Cancer Inst 2008 100: 630-641. [Abstract] [Full Text] [PDF]

Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Receptor Agonist Antibody
Anil Shanker, Alan David Brooks, Carlos Alberto Tristan, John William Wine, Peter John Elliott, Hideo Yagita, Kazuyoshi Takeda, Mark John Smyth, William Joseph Murphy, and Thomas Joseph Sayers
J Natl Cancer Inst 2008 100: 649-662. [Abstract] [Full Text] [PDF]

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Xiaoxian Li, Michael T. Lewis, Jian Huang, Carolina Gutierrez, C. Kent Osborne, Meng-Fen Wu, Susan G. Hilsenbeck, Anne Pavlick, Xiaomei Zhang, Gary C. Chamness, Helen Wong, Jeffrey Rosen, and Jenny C. Chang
J Natl Cancer Inst 2008 100: 672-679. [Abstract] [Full Text] [PDF]

A Model Citizen? Is Tamoxifen More Effective Than Aromatase Inhibitors if We Pick the Right Patients?
Daniel F. Hayes, Vered Stearns, James Rae, and David Flockhart on behalf of the Consortium on Breast Cancer Pharmacogenomics
J Natl Cancer Inst 2008 100: 610-613. [Extract] [Full Text] [PDF]

Routine Audit of Large-Scale Cervical Cancer Screening Programs
Jack Cuzick
J Natl Cancer Inst 2008 100: 605-606. [Extract] [Full Text] [PDF]

Estimating the Cost of Cancer Care in the United States: A Work Very Much in Progress
Joseph Lipscomb
J Natl Cancer Inst 2008 100: 607-610. [Extract] [Full Text] [PDF]